Forte Biosciences Stock (NASDAQ:FBRX)
Previous Close
$13.84
52W Range
$4.11 - $28.68
50D Avg
$9.57
200D Avg
$10.58
Market Cap
$89.93M
Avg Vol (3M)
$90.44K
Beta
2.86
Div Yield
-
FBRX Company Profile
Forte Biosciences, Inc. operates as a clinical-stage biopharmaceutical company in the United States. It is developing FB-102 program that addresses various autoimmune diseases, such as vitiligo and alopecia areata. The company is headquartered in Dallas, Texas.